US 12144867
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted A61KA61K47/6807A61K47/6849
Quick answer
US patent 12144867 (Muscle targeting complexes and uses thereof for treating dystrophinopathies) held by Dyne Therapeutics, Inc. expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Dyne Therapeutics, Inc.
- Grant date
- Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K47/6807, A61K47/6849, A61K47/6889, A61P